rs11814752

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020987.5(ANK3):​c.1887+1653C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.104 in 152,234 control chromosomes in the GnomAD database, including 1,028 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 1028 hom., cov: 33)

Consequence

ANK3
NM_020987.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.04

Publications

2 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.167 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020987.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
NM_020987.5
MANE Select
c.1887+1653C>T
intron
N/ANP_066267.2
ANK3
NM_001204404.2
c.1836+1653C>T
intron
N/ANP_001191333.1
ANK3
NM_001320874.2
c.1887+1653C>T
intron
N/ANP_001307803.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
ENST00000280772.7
TSL:1 MANE Select
c.1887+1653C>T
intron
N/AENSP00000280772.1
ANK3
ENST00000373827.6
TSL:1
c.1869+1653C>T
intron
N/AENSP00000362933.2
ANK3
ENST00000503366.6
TSL:2
c.1836+1653C>T
intron
N/AENSP00000425236.1

Frequencies

GnomAD3 genomes
AF:
0.103
AC:
15737
AN:
152118
Hom.:
1027
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.170
Gnomad AMI
AF:
0.0899
Gnomad AMR
AF:
0.0724
Gnomad ASJ
AF:
0.0779
Gnomad EAS
AF:
0.0649
Gnomad SAS
AF:
0.117
Gnomad FIN
AF:
0.0519
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0816
Gnomad OTH
AF:
0.105
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.104
AC:
15763
AN:
152234
Hom.:
1028
Cov.:
33
AF XY:
0.101
AC XY:
7529
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.170
AC:
7056
AN:
41520
American (AMR)
AF:
0.0723
AC:
1106
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0779
AC:
270
AN:
3466
East Asian (EAS)
AF:
0.0650
AC:
337
AN:
5182
South Asian (SAS)
AF:
0.118
AC:
569
AN:
4828
European-Finnish (FIN)
AF:
0.0519
AC:
550
AN:
10600
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.0816
AC:
5548
AN:
68020
Other (OTH)
AF:
0.105
AC:
222
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
722
1444
2167
2889
3611
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0899
Hom.:
448
Bravo
AF:
0.106
Asia WGS
AF:
0.0980
AC:
342
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.42
DANN
Benign
0.25
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11814752; hg19: chr10-61954250; API